Exogenous Hydrogen Sulfide Alleviates-Induced Intracellular Inflammation in HepG2 Cells

Abstract

Fatty acids induced hepatic inflammation plays an important role in nonalcoholic fatty liver disease (NAFLD) pathogenesis. Hydrogen sulfide (H₂S), an endogenous gasotransmitter, has been established to possess potent anti-inflammation in various human organs. However, the anti-inflammation property of H₂S in the fatty liver is still needed to further elucidate. Hence, this study aimed to investigate whether exogenous H₂S can protect hepatocytes against inflammation induced by palmitic acid (PA). HepG2 hepatocytes were exposed to PA for 24 h to induce free fatty acids-induced inflammation. The cells were pretreated with NaHS (a donor of H₂S) before exposure to PA. Cell viability, inflammatory cytokines (TNF-α, IL-6 and IL-1β), NLRP3 inflammasome and NF-κB were measured by a combination of MTT assay, ELISA, Western blot and Immunofluorescence. Here, we found that exogenous H₂S dose-dependently inhibited the expression of pro-inflammatory cytokines, NLRP3 inflammasome and activation of NF-κB signaling in PA-induced HepG2 cells. Thus, H₂S might be a candidate therapeutic agent against NAFLD.

Key words

hydrogen sulfide (H₂S) - nonalcoholic fatty liver disease (NAFLD) - inflammation - NLRP3

• References

• 1 Bugianesi E, Rosso C, Cortez-Pinto H. How to diagnose NAFLD in 2016. J Hepatol 2016; 65: 643-644
• 2 Day CP. Non-alcoholic fatty liver disease: A massive problem. Clin Med (Lond) 2011; 11: 176-178
• 3 Zhao XJ, Yang YZ, Zheng YJ. et al. Magnesium isoglycyrrhizinate blocks fructose-induced hepatic NF-κB/NLRP3 inflammasome activation and lipid metabolism disorder. Eur J Pharmacol 2017; 809: 141-150
• 4 Lalor PF, Faint J, Aarbodem Y. et al. The role of cytokines and chemokines in the development of steatohepatitis. Semin Liver Dis 2007; 27: 173-193
• 5 Wang R. Two’s company, three’s a crowd. Can H₂S be the third endogenous gaseous transmitter?. FASEB J 2002; 16: 1792-1798
• 6 Li M, Xu C, Shi J et al. Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway. Gut 2017, pii: gutjnl-2017-313778
• 7 Sarna LK, Siow YL. OK The CBS/CSE system: A potential therapeutic target in NAFLD?. Can J Physiol Pharmacol 2015; 93: 1-11
• 8 Peh MT, Anwar AB, Ng DS. et al. Effect of feeding a high fat diet on hydrogen sulfide (H₂S) metabolism in the mouse. Nitric Oxide 2014; 41: 138-146
• 9 Sun L, Zhang S, Yu C. et al. Hydrogen sulfide reduces serum triglyceride by activating liver autophagy via the AMPK-mTOR pathway. Am J Physiol Endocrinol Metab 2015; 309: E925-E935
• 10 Wu D, Zheng N, Qi K. et al. Exogenous hydrogen sulfide mitigates the fatty liver in obese mice through improving lipid metabolism and antioxidant potential. Med Gas Res 2015; 5: 1
• 11 Luo ZL, Tang LJ, Wang T. et al. Effects of treatment with hydrogen sulfide on methionine-choline deficient diet-induced non-alcoholic steatohepatitis in rats. J Gastroenterol Hepatol 2014; 29: 215-222
• 12 Alisi A, Carpino G, Oliveira FL. et al. The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications. Mediators Inflamm 2017; 2017: 8162421
• 13 Askari H, Seifi B, Kadkhodaee M. et al. Protective effects of hydrogen sulfide on chronic kidney disease by reducing oxidative stress, inflammation and apoptosis. EXCLI J 2018; 17: 14-23
• 14 Jensen AR, Drucker NA, Khaneki S. et al. Hydrogen sulfide improves intestinal recovery following ischemia by endothelial nitric oxide-dependent mechanisms. Am J Physiol Gastrointest Liver Physiol 2017; 312: G450-G456
• 15 Rao CY, Fu LY, Hu CL. et al. H2S mitigates severe acute pancreatitis through the PI3K/AKT-NF-κB pathway in vivo. World J Gastroenterol 2015; 21: 4555-4563
• 16 Zimmermann KK, Spassov SG, Strosing KM. et al. Hydrogen sulfide exerts anti-oxidative and anti-inflammatory effects in acute lung injury. Inflammation 2018; 41: 249-259
• 17 Zhao H, Qu J, Li Q. et al. Taurine supplementation reduces neuroinflammation and protects against white matter injury after intracerebral hemorrhage in rats. Amino Acids 2018; 50: 439-451
• 18 Bruzzese L, Fromonot J, By Y. et al. NF-κB enhances hypoxia-driven T-cell immunosuppression via upregulation of adenosine A(2A) receptors. Cell Signal 2014; 26: 1060-1067
• 19 Olas B. Hydrogen sulfide as a “Double-Faced” compound: One with pro- and antioxidant effect. Adv Clin Chem 2017; 78: 187-196
• 20 Papapetropoulos A, Pyriochou A, Altaany Z. et al. Hydrogen sulfide is an endogenous stimulator of angiogenesis. P Natl Acad Sci USA 2009; 106: 21972-21977
• 21 Peng YJ, Nanduri J, Raghuraman G. et al. H₂S mediates O₂ sensing in the carotid body. Proc Natl Acad Sci USA 2010; 107: 10719-10724
• 22 Caro AA, Thompson S, Tackett J. Increased oxidative stress and cytotoxicity by hydrogen sulfide in HepG2 cells overexpressing cytochrome P4502E1. Cell Biol Toxicol 2011; 27: 439-453
• 23 Hine C, Kim HJ, Zhu Y. et al. Hypothalamic-pituitary axis regulates hydrogen sulfide production. Cell Metab 2017; 25: 1320-1333
• 24 Cuevasanta E, Möller MN, Alvarez B. Biological chemistry of hydrogen sulfide and persulfides. Arch Biochem Biophys 2017; 617: 9-25
• 25 Yang G. Hydrogen sulfide in cell survival: A double-edged sword. Expert Rev Clin Pharmacol 2011; 4: 33-47
• 26 Wu D, Wang H, Teng T et al. Hydrogen sulfide and autophagy: A double edged sword. Pharmacol Res 2018 pii: S1043- 6618(17)31410-X
• 27 Li M, Xu C, Shi J. et al. Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfde pathway. Gut 2018; 67: 2169-2180
• 28 Li W, Ma F, Zhang L. et al. S-Propargyl-cysteine exerts a novel protective effect on methionine and choline deficient diet-induced fatty liver via Akt/Nrf2/HO-1 Pathway. Oxid Med Cell Longev 2016; 2016: 4690857
• 29 Szabo G, Csak T. Inflammasomes in liver diseases. J Hepatol 2012; 57: 642-654
• 30 Wree A, McGeough MD, Peña CA. et al. NLRP3 inflammasome activation is required for fibrosis development in NAFLD. J Mol Med (Berl) 2014; 92: 1069-1082
• 31 Petrasek J, Bala S, Csak T. et al. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest 2012; 122: 3476-3489
• 32 Huang Z, Zhuang X, Xie C. et al. Exogenous hydrogen sulfide attenuates high glucose-induced cardiotoxicity by inhibiting NLRP3 inflammasome activation by suppressing TLR4/NF-κB pathway in H9c2 cells. Cell Physiol Biochem 2016; 40: 1578-1590
• 33 Luo ZL, Ren JD, Huang Z. et al. The role of exogenous hydrogen sulfide in free fatty acids induced inflammation in macrophages. Cell Physiol Biochem 2017; 42: 1635-1644
• 34 Zhao H, Pan P, Yang Y. et al. Endogenous hydrogen sulphide attenuates NLRP3 inflammasome-mediated neuroinflammation by suppressing the P2X7 receptor after intracerebral haemorrhage in rats. J Neuroinflammation 2017; 14: 163
• 35 Wang P, Qiao Q, Li J. et al. Inhibitory effects of geraniin on LPS-induced inflammation via regulating NF-kB and Nrf2 pathways in RAW 264.7 cells. Chem Biol Interact 2016; 253: 134-142
• 36 Boaru SG, Borkham-Kamphorst E, Van de Leur E. et al. NLRP3 inflammasome expression is driven by NF-kB in cultured hepatocytes. Biochem Biophys Res Commun 2015; 458: 700-706
• 37 Jeong JB, Jeong HJ. Rheosmin, a naturally occurring phenolic compound inhibits LPS-induced iNOS and COX-2 expression in RAW264.7 cells by blocking NF-jB activation pathway. Food Chem Toxicol 2010; 48: 2148-2153
• 38 Kim YS, Ahn CB, Je JY. Anti-inflammatory action of high molecular weight Mytilus edulis hydrolysates fraction in LPS-induced RAW264.7 macrophage via NF-kB and MAPK pathways. Food Chem 2016; 202: 9-14
• 39 Wang Y, Cao J, Fan Y. et al. Artemisinin inhibits monocyte adhesion to HUVECs through the NF-κB and MAPK pathways in vitro. Int J Mol Med 2016; 37: 1567-1575
• 40 Yeom Mijung, Kim Jae-Hyun, Min Ju-Hee. et al. Xanthii fructus inhibits inflammatory responses in LPS-stimulated RAW 264.7 macrophages through suppressing NF-κB and JNK/p38 MAPK. Journal of Ethnopharmacology 2015; 176: 394-401
• 41 Stojsavljević S, Gomerčić Palčić M, Virović Jukić L. et al. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol 2014; 20: 18070-18091